Bi-specific T-cell engager specific for BCMA

    公开(公告)号:US11492408B2

    公开(公告)日:2022-11-08

    申请号:US15028113

    申请日:2014-10-10

    Abstract: The present invention provides a bi-specific molecule which comprises: (i) a first domain which binds B cell maturation antigen (BCMA) and comprises at least part of a proliferation-inducing ligand (APRIL); and (ii) a second domain capable of activating a T cell. The invention also provides the use of such a molecule in the treatment of plasma-cell mediated diseases, such as multiple myeloma.

Patent Agency Ranking